Rise Advisors, LLC: BKR position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Rise Advisors, LLC on BKR, newest first. How the timeline and the estimate are built.
Rise Advisors, LLC held 0 BKR shares at 2025-12-31 per its 13F-HR filed 2026-02-11.
the latest 13F is the newest step
- period ended2025-12-3113F 0 sharesChange vs previous 13F -1,635 shares
13F-HR 0001831316-26-000001 filed by Rise Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2025-09-3013F 1,635 sharesChange vs previous 13F +36 shares
0.03% of the 13F portfolio, value $79,662.
13F-HR 0001831316-25-000007 filed by Rise Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 1,599 sharesChange vs previous 13F +3 shares
0.02% of the 13F portfolio, value $61,314.
13F-HR 0001831316-25-000006 filed by Rise Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 1,596 sharesChange vs previous 13F -100 shares
0.03% of the 13F portfolio, value $70,141.
13F-HR 0001831316-25-000005 filed by Rise Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 1,696 sharesChange vs previous 13F -67 shares
0.03% of the 13F portfolio, value $69,556.
13F-HR 0001831316-25-000001 filed by Rise Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 1,763 sharesChange vs previous 13F not available
0.03% of the 13F portfolio, value $63,715.
13F-HR 0001831316-24-000004 filed by Rise Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).